Multi-drug-resistant Gram-negative bacteria causing urinary tract infections: a review

In vitro activity of fosfomycin trometamol and other oral antibiotics against multidrug-resistant uropathogens

(2017) Maria Lina Mezzatesta et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Susceptibility of contemporary isolates to fosfomycin: a systematic review of the literature

(2016) Konstantinos Z. Vardakas et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Unknown

(2016)   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Molecular epidemiology and characterization of an outbreak causing Klebsiella pneumoniae clone carrying chromosomally located bla CTX-M-15 at a German University-Hospital

(2015) Stephen E. Mshana et al.   BMC MICROBIOLOGY

The Role of Epidemic Resistance Plasmids and International High-Risk Clones in the Spread of Multidrug-Resistant Enterobacteriaceae

(2015) Amy J. Mathers et al.   CLINICAL MICROBIOLOGY REVIEWS

Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin

(2015) Yang Hyun Cho et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Molecular characterization of extended spectrum beta-lactamases produced by Klebsiella pneumoniae clinical strains from a Tunisian Hospital

(2015) S. Alibi et al.   MEDECINE ET MALADIES INFECTIEUSES

Urinary tract infections: epidemiology, mechanisms of infection and treatment options

(2015) Ana L. Flores-Mireles et al.   NATURE REVIEWS MICROBIOLOGY

Epidemiology and Management of Emerging Drug-Resistant Gram-Negative Bacteria

(2015) Daniel P. Boyle et al.   UROLOGIC CLINICS OF NORTH AMERICA

CLSI ve EUCAST Önerilerine Göre Genişlemiş Spektrumlu Beta-Laktamaz Üreten Escherichia coli İdrar İzolatlarında Fosfomisin Duyarlılığı

(2015) Sabahat ÇAĞAN AKTAŞ et al.   MIKROBIYOLOJI BULTENI

Evolution of the resistance to antibiotics of bacteria involved in urinary tract infections: A 7-year surveillance study

(2014) Antonio Sorlozano et al.   AMERICAN JOURNAL OF INFECTION CONTROL

In vitro susceptibility of Escherichia colistrains isolated from urine samples obtained in mainland China to fosfomycin trometamol and other antibiotics: a 9-year surveillance study (2004–2012)

(2014) Bei Lai et al.   BMC INFECTIOUS DISEASES

Occurrence of multidrug resistance to oral antibiotics among Escherichia coli urine isolates from outpatient departments in Germany: Extended-spectrum β-lactamases and the role of fosfomycin

(2014) Michael Kresken et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Susceptibility of Escherichia coli from Community-Acquired Urinary Tract Infection to Fosfomycin, Nitrofurantoin, and Temocillin in Korea

(2014) Mi-Ran Seo et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Frequency and antibiotic susceptibility patterns of urinary pathogens in male outpatients in Argentina

(2014) Hugo E Villar et al.   Journal of Infection in Developing Countries

Identification of Extended-Spectrum-β-Lactamase-Positive Klebsiella pneumoniae Urinary Tract Isolates Harboring KPC and CTX-M β-Lactamases in Nonhospitalized Patients

(2013) Joanna Kopacz et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VitroActivity of Fosfomycin against Escherichia coli Isolated from Patients with Urinary Tract Infections in Canada as Part of the CANWARD Surveillance Study

(2013) James A. Karlowsky et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Distribution of Extended-Spectrum β-Lactamases, AmpC β-Lactamases, and Carbapenemases among Enterobacteriaceae Isolates Causing Intra-Abdominal Infections in the Asia-Pacific Region: Results of the Study for Monitoring Antimicrobial Resistance Trends (SMART)

(2013) Wang-Huei Sheng et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Evaluation of fosfomycin activity against uropathogens in a fosfomycin-naive population in South India: a prospective study

(2013) Rani Diana Sahni et al.   Future Microbiology

Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community- and hospital-acquired urinary tract infections in Turkey

(2013) Tulin Demir et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Escherichia coli belonging to the worldwide emerging epidemic clonal group O25b/ST131: risk factors and clinical implications

(2013) L. Lopez-Cerero et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Alternatives to carbapenems in ESBL-producing Escherichia coli infections

(2013) D. Fournier et al.   MEDECINE ET MALADIES INFECTIEUSES

Characterization of Enterobacteriaceae Isolates Obtained from a Tertiary Care Hospital in Mexico, Which Produces Extended-Spectrum β-Lactamase

(2013) Rayo Morfín-Otero et al.   Microbial Drug Resistance

Increasing prevalence of ciprofloxacin resistance in extended-spectrum-β-lactamase-producing Escherichia coli urinary isolates

(2013) G. Bonkat et al.   WORLD JOURNAL OF UROLOGY

Characteristics of urinary tract infection pathogens and their in vitro susceptibility to antimicrobial agents in China: data from a multicenter study

(2013) Lu-Dong Qiao et al.   BMJ Open

Multiresistant Uropathogenic Escherichia coli from a Region in India Where Urinary Tract Infections Are Endemic: Genotypic and Phenotypic Characteristics of Sequence Type 131 Isolates of the CTX-M-15 Extended-Spectrum-β-Lactamase-Producing Lineage

(2012) Arif Hussain et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Genetic support and diversity of acquired extended-spectrum β-lactamases in Gram-negative rods

(2012) Laurent Poirel et al.   INFECTION GENETICS AND EVOLUTION

Using Nucleic Acid Microarrays To Perform Molecular Epidemiology and Detect Novel  -Lactamases: a Snapshot of Extended-Spectrum  -Lactamases throughout the World

(2012) C. Lascols et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Virulence Potential and Genomic Mapping of the Worldwide Clone Escherichia coli ST131

(2012) Jean-Philippe Lavigne et al.   PLoS One

Susceptibility ofKlebsiella pneumoniaeIsolates from Intra-Abdominal Infections and Molecular Characterization of Ertapenem-Resistant Isolates

(2011) Stephen P. Hawser et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases

(2011) Kalpana Gupta et al.   CLINICAL INFECTIOUS DISEASES

Susceptibility of European Escherichia coli clinical isolates from intra-abdominal infections, extended-spectrum β-lactamase occurrence, resistance distribution, and molecular characterization of ertapenem-resistant isolates (SMART 2008–2009)

(2011) S.P. Hawser et al.   CLINICAL MICROBIOLOGY AND INFECTION

Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy

(2011) S. Meier et al.   INFECTION

Increasing prevalence and dissemination of NDM-1 metallo- -lactamase in India: data from the SMART study (2009)

(2011) C. Lascols et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan

(2011) Hsin-Yi Liu et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Oral Treatment Options for Ambulatory Patients with Urinary Tract Infections Caused by Extended-Spectrum- -Lactamase-Producing Escherichia coli

(2010) S. Auer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prevalence of Fosfomycin Resistance among CTX-M-Producing Escherichia coli Clinical Isolates in Japan and Identification of Novel Plasmid-Mediated Fosfomycin-Modifying Enzymes

(2010) J.-i. Wachino et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Extended-spectrum β-lactamase producing Escherichia coli: changing epidemiology and clinical impact

(2010) Jesús Oteo et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Characterisation of the CTX-M-15-encoding gene in Klebsiella pneumoniae strains from the Barcelona metropolitan area: plasmid diversity and chromosomal integration

(2010) Alicia Coelho et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Fosfomycin susceptibility among extended-spectrum- -lactamase-producing Escherichia coli in Nottingham, UK

(2010) R. J. Chislett et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Prevalence of transferable blaCTX-M-15 from hospital- and community-acquired Klebsiella pneumoniae isolates in Scotland

(2010) A. Younes et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antibiotic susceptibility of unselected uropathogenic Escherichia coli from female Dutch general practice patients: a comparison of two surveys with a 5 year interval

(2010) C. D. J. den Heijer et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Hospital-Acquired Infections Due to Gram-Negative Bacteria

(2010) Anton Y. Peleg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Detection of three stable genetic clones of CTX-M-15-producing Klebsiella pneumoniae in the Barcelona metropolitan area, Spain

(2009) Alicia Coelho et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin

(2009) J. Oteo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup

(2008) Olivier Clermont et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY